Johnson & Johnson MedTech announces the launch of the Cereglide 92 catheter, a new-generation device for neurovascular interventions. J&J highlights its 0.092' internal diameter, which facilitates insertion and guidance of interventional devices for the treatment of acute ischemic stroke and bleeding complications. This catheter offers extended distal access and full visibility under fluoroscopy thanks to BRITE-LINE technology. The device is now available in the United States. Copyright (c) 2025 CercleFinance.com. All rights reserved.
